Checkpoint Capital »

Corcept Therapeutics Incorporated shares owned by Checkpoint Capital

Quarter-by-quarter ownership of Corcept Therapeutics Incorporated (CORT) shares owned by Checkpoint Capital from 13F filings

Historical chart of Checkpoint Capital investment in Corcept Therapeutics Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Corcept Therapeutics Incorporated held by Checkpoint Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Corcept Therapeutics Incorporated by Checkpoint Capital

Quarter filed Position value Share count Share price at filing
2024-06-30 $8.0M 245k 32.49
2024-03-31 $6.9M 274k 25.19

More positions owned by Checkpoint Capital

Rhythm Pharmaceuticals (RYTM)
Argenx Se Sponsored Adr (ARGX)
Axsome Therapeutics (AXSM)
Avadel Pharmaceuticals Com Shs (AVDL)
Protagonist Therapeutics (PTGX)
Cytokinetics Com New (CYTK)
Phathom Pharmaceuticals (PHAT)
Corcept Therapeutics Incorporated (CORT)
Atyr Pharma Com New (ATYR)
Pliant Therapeutics (PLRX)
Kymera Therapeutics (KYMR)
Cidara Therapeutics Com New (CDTX)
Trevi Therapeutics (TRVI)
Applied Therapeutics (APLT)
Soleno Therapeutics (SLNO)

View all positions for Checkpoint Capital

Top funds holding Corcept Therapeutics Incorporated

BlackRock
BlackRock
Vanguard Group
Ingalls & Snyder
Renaissance Technologies
Parallel Advisors
State Street Corporation
Dimensional Fund Advisors
Novo A/S
Geode Capital Management
Arrowstreet Capital, Limited Partnership
Btim
First Trust Advisors
Morgan Stanley
Jacobs Levy Equity Management

View all funds holding Corcept Therapeutics Incorporated